Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

Expression of human heparanase protein and production of monoclonal antibodies against human heparanase

Microsoft Word-Yuan et al PDF

Preparation and characterization of a novel monoclonal antibody against human PD-1

[Expression of recombinant human hemangiopoietin and preparation of its polyclonal antibody]

Establishment of Heparanase Stable Expression Cell Lines

Expression,purification and preparation of monoclonal antibody of HCA518 protein

Expression and purification of human PrP-like protein Shadoo and preparation of antibody against Shadoo

High-Level Expression and Purification of Recombinant Heparinase Ⅰ in Escherichia Coli

Preparation and Characterization of Monoclonal Antibody Against Human Angiopoietin-Like Protein 2

Preparation and Identification of Monoclonal Antibodies Against Humanin

[Expression of GST-HAI-1 Fusion Protein and Development of Monoclonal Antibody Against Human Hepatocyte Growth Factor Activator Inhibitor 1].

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Preparation and Characterization of the Monoclonal Antibody Against HSPC238 Antigen

Expression of Epitopes of Human Inhibin Subunits and Preparation of Its Antibodies

Prokaryotic Expression of Endostat in and Preparation of Polyclonal Antibody

The Cloning and Expression of Renalase and the Preparation of Its Monoclonal Antibody

Prokaryotic Expression and Preparation of Polyantibody of Human Histydyl-Trna Synthetase Related Gene

Prokaryotic Expression and Purification of HIV-1 Vif and Hapobec3g, Preparation of Polyclonal Antibodies

Prokaryotic Expression of Soluble NH2-terminal Fragment of Glypican-3 and Preparation of Anti-Gpc3 Antibody

Preparation and Characterization of Monoclonal Antibodies Against Mouse Estrogen-Enhanced Transcript

[Recombinant Expression of Human Fibrogenic Factors and Preparation of Polyclonal Antibodies].